Actisomide
Names | |
---|---|
IUPAC name
(4R,4aR)-4-[2-[Di(propan-2-yl)amino]ethyl]-1-methyl-4-phenyl-5,6,7,8-tetrahydro-4aH-pyrido[1,2-c]pyrimidin-3-one | |
Identifiers | |
96914-39-5 | |
ChEMBL | ChEMBL286259 |
ChemSpider | 5293118 |
Jmol interactive 3D | Image |
KEGG | D02762 |
MeSH | C051827 |
PubChem | 6917898 |
| |
| |
Properties | |
C23H35N3O | |
Molar mass | 369.55 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
Infobox references | |
Actisomide is an antiarrhythmic drug.[1]
Synthesis
References
- ↑ Cook, CS; Rozek, LF; Stolzenbach, J; Anderson, S; Schoenhard, GL; Karim, A (1993). "Pharmacokinetics of a novel antiarrhythmic drug, actisomide". Pharmaceutical Research 10 (3): 427–33. doi:10.1023/a:1018900725050. PMID 8464818.
- ↑ Chorvat, Robert J.; Prodan, Kathleen A.; Adelstein, Gilbert W.; Rydzewski, Robert M.; McLaughlin, Kathleen T.; Stamm, Margarete H.; Frederick, Leo G.; Schniepp, Henry C.; Stickney, Janice L. (1985). "Synthesis and structure-activity relationships of a new series of antiarrhythmic agents: 4,4-disubstituted hexahydro-3H-pyrido[1,2-c]pyrimidin-3-ones and related compounds". Journal of Medicinal Chemistry 28 (9): 1285. doi:10.1021/jm00147a029. PMID 4032431.
This article is issued from Wikipedia - version of the Friday, November 13, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.